Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neurosciences and Rare Diseases. Ipsen also has a well-established Consumer Healthcare business, with the most successful brands as Smecta, Tanakan, Forlax and continues to grow presenting new launches in gastroenterology.